{
  "DOI": "10.1007/s00439-017-1789-4",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-017-1789-4",
  "alternative-id": [
    "1789"
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-4498-7420",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Kataoka",
      "given": "Naoyuki",
      "sequence": "first"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        3,
        31
      ]
    ],
    "date-time": "2017-03-31T04:23:33Z",
    "timestamp": 1490934213000
  },
  "deposited": {
    "date-parts": [
      [
        2017,
        9,
        16
      ]
    ],
    "date-time": "2017-09-16T14:57:19Z",
    "timestamp": 1505573839000
  },
  "funder": [
    {
      "award": [
        "23112706"
      ],
      "name": "Ministry of Education, Culture, Sports, Science and Technology (JP)"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        20
      ]
    ],
    "date-time": "2023-11-20T14:57:09Z",
    "timestamp": 1700492229520
  },
  "is-referenced-by-count": 22,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "9",
  "issued": {
    "date-parts": [
      [
        2017,
        3,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "9",
    "published-print": {
      "date-parts": [
        [
          2017,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            3,
            31
          ]
        ],
        "date-time": "2017-03-31T00:00:00Z",
        "timestamp": 1490918400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-017-1789-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-017-1789-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-017-1789-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1237-1245",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        3,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        3,
        31
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1089/nat.2016.0657",
      "author": "A Aartsma-Rus",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Nucleic Acid Ther",
      "key": "1789_CR1",
      "unstructured": "Aartsma-Rus A, Krieg AM (2017) FDA approves eteplirsen for duchenne muscular dystrophy: the next chapter in the eteplirsen saga. Nucleic Acid Ther 27:1–3. doi:\n                        10.1089/nat.2016.0657",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.1086/318808",
      "author": "SL Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "753",
      "journal-title": "Am J Hum Genet",
      "key": "1789_CR2",
      "unstructured": "Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, Ekstein J, Rubin BY (2001) Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 68:753–758. doi:\n                        10.1086/318808",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.bbrc.2003.09.019",
      "author": "SL Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "627",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "1789_CR3",
      "unstructured": "Anderson SL, Qiu J, Rubin BY (2003a) EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem Biophys Res Commun 310:627–633",
      "volume": "310",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0006-291X(03)00971-9",
      "author": "SL Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "303",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "1789_CR4",
      "unstructured": "Anderson SL, Qiu J, Rubin BY (2003b) Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem Biophys Res Commun 306:303–309",
      "volume": "306",
      "year": "2003"
    },
    {
      "DOI": "10.1093/hmg/10.24.2841",
      "author": "C Andreassi",
      "doi-asserted-by": "crossref",
      "first-page": "2841",
      "journal-title": "Hum Mol Genet",
      "key": "1789_CR5",
      "unstructured": "Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, Whitney M, Pollok B, Zhang M, Androphy E, Burghes AH (2001) Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10:2841–2849",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1203/PDR.0b013e31822e1825",
      "author": "FB Axelrod",
      "doi-asserted-by": "publisher",
      "first-page": "480",
      "journal-title": "Pediatr Res",
      "key": "1789_CR6",
      "unstructured": "Axelrod FB, Liebes L, Gold-Von Simson G, Mendoza S, Mull J, Leyne M, Norcliffe-Kaufmann L, Kaufmann H, Slaugenhaupt SA (2011) Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res 70:480–483. doi:\n                        10.1203/PDR.0b013e31822e1825",
      "volume": "70",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/ddt126",
      "author": "R Bochner",
      "doi-asserted-by": "publisher",
      "first-page": "2785",
      "journal-title": "Hum Mol Genet",
      "key": "1789_CR7",
      "unstructured": "Bochner R, Ziv Y, Zeevi D, Donyo M, Abraham L, Ashery-Padan R, Ast G (2013) Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model. Hum Mol Genet 22:2785–2794. doi:\n                        10.1093/hmg/ddt126",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1124/jpet.107.123000",
      "author": "T Bordet",
      "doi-asserted-by": "publisher",
      "first-page": "709",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "1789_CR8",
      "unstructured": "Bordet T, Buisson B, Michaud M, Drouot C, Galea P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapere JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM (2007) Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther 322:709–720. doi:\n                        10.1124/jpet.107.123000",
      "volume": "322",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ng854",
      "author": "L Cartegni",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "journal-title": "Nat Genet",
      "key": "1789_CR9",
      "unstructured": "Cartegni L, Krainer AR (2002) Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377–384. doi:\n                        10.1038/ng854",
      "volume": "30",
      "year": "2002"
    },
    {
      "DOI": "10.1038/nrg775",
      "author": "L Cartegni",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nat Rev Genet",
      "key": "1789_CR10",
      "unstructured": "Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285–298. doi:\n                        10.1038/nrg775",
      "volume": "3",
      "year": "2002"
    },
    {
      "DOI": "10.1182/blood-2013-09-381665",
      "author": "M Cazzola",
      "doi-asserted-by": "publisher",
      "first-page": "4021",
      "journal-title": "Blood",
      "key": "1789_CR11",
      "unstructured": "Cazzola M, Della Porta MG, Malcovati L (2013) The genetic basis of myelodysplasia and its clinical relevance. Blood 122:4021–4034. doi:\n                        10.1182/blood-2013-09-381665",
      "volume": "122",
      "year": "2013"
    },
    {
      "DOI": "10.1073/pnas.171105098",
      "author": "JG Chang",
      "doi-asserted-by": "publisher",
      "first-page": "9808",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1789_CR12",
      "unstructured": "Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98:9808–9813. doi:\n                        10.1073/pnas.171105098",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1101/gad.2014311",
      "author": "A Corrionero",
      "doi-asserted-by": "publisher",
      "first-page": "445",
      "journal-title": "Genes Dev",
      "key": "1789_CR13",
      "unstructured": "Corrionero A, Minana B, Valcarcel J (2011) Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev 25:445–459. doi:\n                        10.1101/gad.2014311",
      "volume": "25",
      "year": "2011"
    },
    {
      "DOI": "10.1086/368263",
      "author": "MP Cuajungco",
      "doi-asserted-by": "publisher",
      "first-page": "749",
      "journal-title": "Am J Hum Genet",
      "key": "1789_CR14",
      "unstructured": "Cuajungco MP, Leyne M, Mull J, Gill SP, Lu W, Zagzag D, Axelrod FB, Maayan C, Gusella JF, Slaugenhaupt SA (2003) Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia. Am J Hum Genet 72:749–758. doi:\n                        10.1086/368263",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.celrep.2015.09.053",
      "author": "RB Darman",
      "doi-asserted-by": "publisher",
      "first-page": "1033",
      "journal-title": "Cell Rep",
      "key": "1789_CR15",
      "unstructured": "Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D, Bailey SL, Bhavsar EB, Chan B, Colla S, Corson L, Feala J, Fekkes P, Ichikawa K, Keaney GF, Lee L, Kumar P, Kunii K, MacKenzie C, Matijevic M, Mizui Y, Myint K, Park ES, Puyang X, Selvaraj A, Thomas MP, Tsai J, Wang JY, Warmuth M, Yang H, Zhu P, Garcia-Manero G, Furman RR, Yu L, Smith PG, Buonamici S (2015) Cancer-associated SF3B1 hotspot mutations induce cryptic 3′ splice site selection through use of a different branch point. Cell Rep 13:1033–1045. doi:\n                        10.1016/j.celrep.2015.09.053",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1002/wrna.1140",
      "author": "L Conti De",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "journal-title": "Wiley Interdiscip Rev RNA",
      "key": "1789_CR16",
      "unstructured": "De Conti L, Baralle M, Buratti E (2013) Exon and intron definition in pre-mRNA splicing. Wiley Interdiscip Rev RNA 4:49–60. doi:\n                        10.1002/wrna.1140",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pcbi.1004105",
      "author": "C DeBoever",
      "doi-asserted-by": "publisher",
      "first-page": "e1004105",
      "journal-title": "PLoS Comput Biol",
      "key": "1789_CR17",
      "unstructured": "DeBoever C, Ghia EM, Shepard PJ, Rassenti L, Barrett CL, Jepsen K, Jamieson CH, Carson D, Kipps TJ, Frazer KA (2015) Transcriptome sequencing reveals potential mechanism of cryptic 3′ splice site selection in SF3B1-mutated cancers. PLoS Comput Biol 11:e1004105. doi:\n                        10.1371/journal.pcbi.1004105",
      "volume": "11",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrc.2016.51",
      "author": "H Dvinge",
      "doi-asserted-by": "publisher",
      "first-page": "413",
      "journal-title": "Nat Rev Cancer",
      "key": "1789_CR18",
      "unstructured": "Dvinge H, Kim E, Abdel-Wahab O, Bradley RK (2016) RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer 16:413–430. doi:\n                        10.1038/nrc.2016.51",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-13-0485",
      "author": "FA Eskens",
      "doi-asserted-by": "publisher",
      "first-page": "6296",
      "journal-title": "Clin Cancer Res",
      "key": "1789_CR19",
      "unstructured": "Eskens FA, Ramos FJ, Burger H, O’Brien JP, Piera A, de Jonge MJ, Mizui Y, Wiemer EA, Carreras MJ, Baselga J, Tabernero J (2013) Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors. Clin Cancer Res 19:6296–6304. doi:\n                        10.1158/1078-0432.CCR-13-0485",
      "volume": "19",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrg3460",
      "author": "RJ Fairclough",
      "doi-asserted-by": "publisher",
      "first-page": "373",
      "journal-title": "Nat Rev Genet",
      "key": "1789_CR20",
      "unstructured": "Fairclough RJ, Wood MJ, Davies KE (2013) Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet 14:373–378. doi:\n                        10.1038/nrg3460",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1021/cb100356k",
      "author": "L Fan",
      "doi-asserted-by": "publisher",
      "first-page": "582",
      "journal-title": "ACS Chem Biol",
      "key": "1789_CR21",
      "unstructured": "Fan L, Lagisetti C, Edwards CC, Webb TR, Potter PM (2011) Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing. ACS Chem Biol 6:582–589. doi:\n                        10.1021/cb100356k",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1101/gad.2009411",
      "author": "EG Folco",
      "doi-asserted-by": "publisher",
      "first-page": "440",
      "journal-title": "Genes Dev",
      "key": "1789_CR22",
      "unstructured": "Folco EG, Coil KE, Reed R (2011) The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region. Genes Dev 25:440–444. doi:\n                        10.1101/gad.2009411",
      "volume": "25",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrg3778",
      "author": "XD Fu",
      "doi-asserted-by": "publisher",
      "first-page": "689",
      "journal-title": "Nat Rev Genet",
      "key": "1789_CR23",
      "unstructured": "Fu XD, Ares M Jr (2014) Context-dependent control of alternative splicing by RNA-binding proteins. Nat Rev Genet 15:689–701. doi:\n                        10.1038/nrg3778",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-016-1683-5",
      "author": "T Geuens",
      "doi-asserted-by": "publisher",
      "first-page": "851",
      "journal-title": "Hum Genet",
      "key": "1789_CR24",
      "unstructured": "Geuens T, Bouhy D, Timmerman V (2016) The hnRNP family: insights into their role in health and disease. Hum Genet 135:851–867. doi:\n                        10.1007/s00439-016-1683-5",
      "volume": "135",
      "year": "2016"
    },
    {
      "DOI": "10.1021/cb100248e",
      "author": "M Hasegawa",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "journal-title": "ACS Chem Biol",
      "key": "1789_CR25",
      "unstructured": "Hasegawa M, Miura T, Kuzuya K, Inoue A, Won Ki S, Horinouchi S, Yoshida T, Kunoh T, Koseki K, Mino K, Sasaki R, Yoshida M, Mizukami T (2011) Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product. ACS Chem Biol 6:229–233. doi:\n                        10.1021/cb100248e",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1126/scitranslmed.3000208",
      "author": "ML Hastings",
      "doi-asserted-by": "publisher",
      "first-page": "5ra12",
      "journal-title": "Sci Transl Med",
      "key": "1789_CR26",
      "unstructured": "Hastings ML, Berniac J, Liu YH, Abato P, Jodelka FM, Barthel L, Kumar S, Dudley C, Nelson M, Larson K, Edmonds J, Bowser T, Draper M, Higgins P, Krainer AR (2009) Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy. Sci Transl Med 1:5ra12. doi:\n                        10.1126/scitranslmed.3000208",
      "volume": "1",
      "year": "2009"
    },
    {
      "DOI": "10.1016/0092-8674(87)90579-4",
      "author": "EP Hoffman",
      "doi-asserted-by": "crossref",
      "first-page": "919",
      "journal-title": "Cell",
      "key": "1789_CR27",
      "unstructured": "Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928",
      "volume": "51",
      "year": "1987"
    },
    {
      "DOI": "10.1007/s10637-013-0046-5",
      "author": "DS Hong",
      "doi-asserted-by": "publisher",
      "first-page": "436",
      "journal-title": "Invest New Drugs",
      "key": "1789_CR28",
      "unstructured": "Hong DS, Kurzrock R, Naing A, Wheler JJ, Falchook GS, Schiffman JS, Faulkner N, Pilat MJ, O’Brien J, LoRusso P (2014) A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors. Invest New Drugs 32:436–444. doi:\n                        10.1007/s10637-013-0046-5",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1002/wrna.1260",
      "author": "JM Howard",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Wiley Interdiscip Rev RNA",
      "key": "1789_CR29",
      "unstructured": "Howard JM, Sanford JR (2015) The RNAissance family: SR proteins as multifaceted regulators of gene expression. Wiley Interdiscip Rev RNA 6:93–110. doi:\n                        10.1002/wrna.1260",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1002/humu.20401",
      "author": "EC Ibrahim",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "Hum Mutat",
      "key": "1789_CR30",
      "unstructured": "Ibrahim EC, Hims MM, Shomron N, Burge CB, Slaugenhaupt SA, Reed R (2007) Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia. Hum Mutat 28:41–53. doi:\n                        10.1002/humu.20401",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nchembio.2007.18",
      "author": "D Kaida",
      "doi-asserted-by": "publisher",
      "first-page": "576",
      "journal-title": "Nat Chem Biol",
      "key": "1789_CR31",
      "unstructured": "Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K, Watanabe H, Kitahara T, Yoshida T, Nakajima H, Tani T, Horinouchi S, Yoshida M (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 3:576–583. doi:\n                        10.1038/nchembio.2007.18",
      "volume": "3",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ng1207",
      "author": "T Kashima",
      "doi-asserted-by": "publisher",
      "first-page": "460",
      "journal-title": "Nat Genet",
      "key": "1789_CR32",
      "unstructured": "Kashima T, Manley JL (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 34:460–463. doi:\n                        10.1038/ng1207",
      "volume": "34",
      "year": "2003"
    },
    {
      "DOI": "10.1126/scitranslmed.3005054",
      "author": "GC Kendall",
      "doi-asserted-by": "publisher",
      "first-page": "164ra160",
      "journal-title": "Sci Transl Med",
      "key": "1789_CR33",
      "unstructured": "Kendall GC, Mokhonova EI, Moran M, Sejbuk NE, Wang DW, Silva O, Wang RT, Martinez L, Lu QL, Damoiseaux R, Spencer MJ, Nelson SF, Miceli MC (2012) Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy. Sci Transl Med 4:164ra160. doi:\n                        10.1126/scitranslmed.3005054",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0015884",
      "author": "H Keren",
      "doi-asserted-by": "publisher",
      "first-page": "e15884",
      "journal-title": "PLoS ONE",
      "key": "1789_CR34",
      "unstructured": "Keren H, Donyo M, Zeevi D, Maayan C, Pupko T, Ast G (2010) Phosphatidylserine increases IKBKAP levels in familial dysautonomia cells. PLoS ONE 5:e15884. doi:\n                        10.1371/journal.pone.0015884",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.addr.2015.05.008",
      "author": "R Kole",
      "doi-asserted-by": "publisher",
      "first-page": "104",
      "journal-title": "Adv Drug Deliv Rev",
      "key": "1789_CR35",
      "unstructured": "Kole R, Krieg AM (2015) Exon skipping therapy for Duchenne muscular dystrophy. Adv Drug Deliv Rev 87:104–107. doi:\n                        10.1016/j.addr.2015.05.008",
      "volume": "87",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nchembio.2007.16",
      "author": "Y Kotake",
      "doi-asserted-by": "publisher",
      "first-page": "570",
      "journal-title": "Nat Chem Biol",
      "key": "1789_CR36",
      "unstructured": "Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 3:570–575. doi:\n                        10.1038/nchembio.2007.16",
      "volume": "3",
      "year": "2007"
    },
    {
      "DOI": "10.1007/BF00210743",
      "author": "M Krawczak",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "journal-title": "Hum Genet",
      "key": "1789_CR37",
      "unstructured": "Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54",
      "volume": "90",
      "year": "1992"
    },
    {
      "DOI": "10.1038/nmeth944",
      "author": "H Kuroyanagi",
      "doi-asserted-by": "publisher",
      "first-page": "909",
      "journal-title": "Nat Methods",
      "key": "1789_CR38",
      "unstructured": "Kuroyanagi H, Kobayashi T, Mitani S, Hagiwara M (2006) Transgenic alternative-splicing reporters reveal tissue-specific expression profiles and regulation mechanisms in vivo. Nat Methods 3:909–915. doi:\n                        10.1038/nmeth944",
      "volume": "3",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nprot.2010.107",
      "author": "H Kuroyanagi",
      "doi-asserted-by": "publisher",
      "first-page": "1495",
      "journal-title": "Nat Protoc",
      "key": "1789_CR39",
      "unstructured": "Kuroyanagi H, Ohno G, Sakane H, Maruoka H, Hagiwara M (2010) Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans. Nat Protoc 5:1495–1517. doi:\n                        10.1038/nprot.2010.107",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1146/annurev-biochem-060614-034316",
      "author": "Y Lee",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "journal-title": "Annu Rev Biochem",
      "key": "1789_CR40",
      "unstructured": "Lee Y, Rio DC (2015) Mechanisms and regulation of alternative pre-mRNA splicing. Annu Rev Biochem 84:291–323. doi:\n                        10.1146/annurev-biochem-060614-034316",
      "volume": "84",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nm.4097",
      "author": "SC Lee",
      "doi-asserted-by": "publisher",
      "first-page": "672",
      "journal-title": "Nat Med",
      "key": "1789_CR41",
      "unstructured": "Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O (2016) Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med 22:672–678. doi:\n                        10.1038/nm.4097",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1016/0092-8674(95)90460-3",
      "author": "S Lefebvre",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "journal-title": "Cell",
      "key": "1789_CR42",
      "unstructured": "Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155–165",
      "volume": "80",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0140-6736(08)60921-6",
      "author": "MR Lunn",
      "doi-asserted-by": "publisher",
      "first-page": "2120",
      "journal-title": "Lancet",
      "key": "1789_CR43",
      "unstructured": "Lunn MR, Wang CH (2008) Spinal muscular atrophy. Lancet 371:2120–2133. doi:\n                        10.1016/S0140-6736(08)60921-6",
      "volume": "371",
      "year": "2008"
    },
    {
      "DOI": "10.1101/gad.1934910",
      "author": "JL Manley",
      "doi-asserted-by": "publisher",
      "first-page": "1073",
      "journal-title": "Genes Dev",
      "key": "1789_CR44",
      "unstructured": "Manley JL, Krainer AR (2010) A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev 24:1073–1074. doi:\n                        10.1101/gad.1934910",
      "volume": "24",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.braindev.2015.05.014",
      "author": "M Matsuo",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "journal-title": "Brain Dev",
      "key": "1789_CR45",
      "unstructured": "Matsuo M, Takeshima Y, Nishio H (2016) Contributions of Japanese patients to development of antisense therapy for DMD. Brain Dev 38:4–9. doi:\n                        10.1016/j.braindev.2015.05.014",
      "volume": "38",
      "year": "2016"
    },
    {
      "DOI": "10.1074/jbc.M314298200",
      "author": "M Muraki",
      "doi-asserted-by": "publisher",
      "first-page": "24246",
      "journal-title": "J Biol Chem",
      "key": "1789_CR46",
      "unstructured": "Muraki M, Ohkawara B, Hosoya T, Onogi H, Koizumi J, Koizumi T, Sumi K, Yomoda J, Murray MV, Kimura H, Furuichi K, Shibuya H, Krainer AR, Suzuki M, Hagiwara M (2004) Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem 279:24246–24254. doi:\n                        10.1074/jbc.M314298200",
      "volume": "279",
      "year": "2004"
    },
    {
      "DOI": "10.1038/nature08909",
      "author": "TW Nilsen",
      "doi-asserted-by": "publisher",
      "first-page": "457",
      "journal-title": "Nature",
      "key": "1789_CR47",
      "unstructured": "Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457–463. doi:\n                        10.1038/nature08909",
      "volume": "463",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ncomms1306",
      "author": "A Nishida",
      "doi-asserted-by": "publisher",
      "first-page": "308",
      "journal-title": "Nat Commun",
      "key": "1789_CR48",
      "unstructured": "Nishida A, Kataoka N, Takeshima Y, Yagi M, Awano H, Ota M, Itoh K, Hagiwara M, Matsuo M (2011) Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat Commun 2:308. doi:\n                        10.1038/ncomms1306",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nchembio.1837",
      "author": "J Palacino",
      "doi-asserted-by": "publisher",
      "first-page": "511",
      "journal-title": "Nat Chem Biol",
      "key": "1789_CR49",
      "unstructured": "Palacino J, Swalley SE, Song C, Cheung AK, Shu L, Zhang X, Van Hoosear M, Shin Y, Chin DN, Keller CG, Beibel M, Renaud NA, Smith TM, Salcius M, Shi X, Hild M, Servais R, Jain M, Deng L, Bullock C, McLellan M, Schuierer S, Murphy L, Blommers MJ, Blaustein C, Berenshteyn F, Lacoste A, Thomas JR, Roma G, Michaud GA, Tseng BS, Porter JA, Myer VE, Tallarico JA, Hamann LG, Curtis D, Fishman MC, Dietrich WF, Dales NA, Sivasankaran R (2015) SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice. Nat Chem Biol 11:511–517. doi:\n                        10.1038/nchembio.1837",
      "volume": "11",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.259",
      "author": "Q Pan",
      "doi-asserted-by": "publisher",
      "first-page": "1413",
      "journal-title": "Nat Genet",
      "key": "1789_CR50",
      "unstructured": "Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413–1415. doi:\n                        10.1038/ng.259",
      "volume": "40",
      "year": "2008"
    },
    {
      "DOI": "10.1124/jpet.113.212407",
      "author": "F Rigo",
      "doi-asserted-by": "publisher",
      "first-page": "46",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "1789_CR51",
      "unstructured": "Rigo F, Chun SJ, Norris DA, Hung G, Lee S, Matson J, Fey RA, Gaus H, Hua Y, Grundy JS, Krainer AR, Henry SP, Bennett CF (2014) Pharmacology of a central nervous system delivered 2′-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. J Pharmacol Exp Ther 350:46–55. doi:\n                        10.1124/jpet.113.212407",
      "volume": "350",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-016-1725-z",
      "author": "JN Robinson-Hamm",
      "doi-asserted-by": "publisher",
      "first-page": "1029",
      "journal-title": "Hum Genet",
      "key": "1789_CR52",
      "unstructured": "Robinson-Hamm JN, Gersbach CA (2016) Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Hum Genet 135:1029–1040. doi:\n                        10.1007/s00439-016-1725-z",
      "volume": "135",
      "year": "2016"
    },
    {
      "DOI": "10.1016/0092-8674(78)90306-9",
      "author": "L Sealy",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "Cell",
      "key": "1789_CR53",
      "unstructured": "Sealy L, Chalkley R (1978) The effect of sodium butyrate on histone modification. Cell 14:115–121",
      "volume": "14",
      "year": "1978"
    },
    {
      "DOI": "10.1016/j.bbadis.2013.08.005",
      "author": "J Seo",
      "doi-asserted-by": "publisher",
      "first-page": "2180",
      "journal-title": "Biochim Biophys Acta",
      "key": "1789_CR54",
      "unstructured": "Seo J, Howell MD, Singh NN, Singh RN (2013) Spinal muscular atrophy: an update on therapeutic progress. Biochim Biophys Acta 1832:2180–2190. doi:\n                        10.1016/j.bbadis.2013.08.005",
      "volume": "1832",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ncomms14060",
      "author": "CL Shirai",
      "doi-asserted-by": "publisher",
      "first-page": "14060",
      "journal-title": "Nat Commun",
      "key": "1789_CR55",
      "unstructured": "Shirai CL, White BS, Tripathi M, Tapia R, Ley JN, Ndonwi M, Kim S, Shao J, Carver A, Saez B, Fulton RS, Fronick C, O’Laughlin M, Lagisetti C, Webb TR, Graubert TA, Walter MJ (2017) Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome. Nat Commun 8:14060. doi:\n                        10.1038/ncomms14060",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1128/MCB.26.4.1333-1346.2006",
      "author": "NK Singh",
      "doi-asserted-by": "publisher",
      "first-page": "1333",
      "journal-title": "Mol Cell Biol",
      "key": "1789_CR56",
      "unstructured": "Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26:1333–1346. doi:\n                        10.1128/MCB.26.4.1333-1346.2006",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1086/318810",
      "author": "SA Slaugenhaupt",
      "doi-asserted-by": "crossref",
      "first-page": "598",
      "journal-title": "Am J Hum Genet",
      "key": "1789_CR57",
      "unstructured": "Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68:598–605",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/ddh046",
      "author": "SA Slaugenhaupt",
      "doi-asserted-by": "publisher",
      "first-page": "429",
      "journal-title": "Hum Mol Genet",
      "key": "1789_CR58",
      "unstructured": "Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13:429–436. doi:\n                        10.1093/hmg/ddh046",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1038/mt.2016.188",
      "author": "CA Stein",
      "doi-asserted-by": "publisher",
      "first-page": "1884",
      "journal-title": "Mol Ther",
      "key": "1789_CR59",
      "unstructured": "Stein CA (2016) Eteplirsen approved for duchenne muscular dystrophy: the FDA faces a difficult choice. Mol Ther 24:1884–1885. doi:\n                        10.1038/mt.2016.188",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pone.0010946",
      "author": "A Takeuchi",
      "doi-asserted-by": "publisher",
      "first-page": "e10946",
      "journal-title": "PLoS ONE",
      "key": "1789_CR60",
      "unstructured": "Takeuchi A, Hosokawa M, Nojima T, Hagiwara M (2010) Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection. PLoS ONE 5:e10946. doi:\n                        10.1371/journal.pone.0010946",
      "volume": "5",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cell.2009.02.009",
      "author": "MC Wahl",
      "doi-asserted-by": "publisher",
      "first-page": "701",
      "journal-title": "Cell",
      "key": "1789_CR61",
      "unstructured": "Wahl MC, Will CL, Luhrmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701–718. doi:\n                        10.1016/j.cell.2009.02.009",
      "volume": "136",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nature07509",
      "author": "ET Wang",
      "doi-asserted-by": "publisher",
      "first-page": "470",
      "journal-title": "Nature",
      "key": "1789_CR62",
      "unstructured": "Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470–476. doi:\n                        10.1038/nature07509",
      "volume": "456",
      "year": "2008"
    },
    {
      "DOI": "10.1093/emboj/cdf480",
      "author": "CL Will",
      "doi-asserted-by": "crossref",
      "first-page": "4978",
      "journal-title": "EMBO J",
      "key": "1789_CR63",
      "unstructured": "Will CL, Urlaub H, Achsel T, Gentzel M, Wilm M, Luhrmann R (2002) Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein. EMBO J 21:4978–4988",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.tig.2010.12.001",
      "author": "JT Witten",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Trends Genet",
      "key": "1789_CR64",
      "unstructured": "Witten JT, Ule J (2011) Understanding splicing regulation through RNA splicing maps. Trends Genet 27:89–97. doi:\n                        10.1016/j.tig.2010.12.001",
      "volume": "27",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature10496",
      "author": "K Yoshida",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "journal-title": "Nature",
      "key": "1789_CR65",
      "unstructured": "Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64–69. doi:\n                        10.1038/nature10496",
      "volume": "478",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.1415525112",
      "author": "M Yoshida",
      "doi-asserted-by": "publisher",
      "first-page": "2764",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1789_CR66",
      "unstructured": "Yoshida M, Kataoka N, Miyauchi K, Ohe K, Iida K, Yoshida S, Nojima T, Okuno Y, Onogi H, Usui T, Takeuchi A, Hosoya T, Suzuki T, Hagiwara M (2015) Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia. Proc Natl Acad Sci USA 112:2764–2769. doi:\n                        10.1073/pnas.1415525112",
      "volume": "112",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.clinthera.2013.11.006",
      "author": "C Zanetta",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "journal-title": "Clin Ther",
      "key": "1789_CR67",
      "unstructured": "Zanetta C, Nizzardo M, Simone C, Monguzzi E, Bresolin N, Comi GP, Corti S (2014) Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials. Clin Ther 36:128–140. doi:\n                        10.1016/j.clinthera.2013.11.006",
      "volume": "36",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1097-2765(01)00409-9",
      "author": "J Zhu",
      "doi-asserted-by": "crossref",
      "first-page": "1351",
      "journal-title": "Mol Cell",
      "key": "1789_CR68",
      "unstructured": "Zhu J, Mayeda A, Krainer AR (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell 8:1351–1361",
      "volume": "8",
      "year": "2001"
    },
    {
      "DOI": "10.1186/1471-2164-10-47",
      "author": "L Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "journal-title": "BMC Genomics",
      "key": "1789_CR69",
      "unstructured": "Zhu L, Zhang Y, Zhang W, Yang S, Chen JQ, Tian D (2009) Patterns of exon-intron architecture variation of genes in eukaryotic genomes. BMC Genomics 10:47. doi:\n                        10.1186/1471-2164-10-47",
      "volume": "10",
      "year": "2009"
    }
  ],
  "reference-count": 69,
  "references-count": 69,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-017-1789-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Modulation of aberrant splicing in human RNA diseases by chemical compounds"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "136"
}